Erik W Bush1, Eva van Rooij2. 1. From miRagen Therapeutics, Inc, Boulder, CO (E.W.B.); and Hubrecht Institute, KNAW, University Medical Center Utrecht, Utrecht, The Netherlands (E.v.R.). 2. From miRagen Therapeutics, Inc, Boulder, CO (E.W.B.); and Hubrecht Institute, KNAW, University Medical Center Utrecht, Utrecht, The Netherlands (E.v.R.). E.vanrooij@hubrecht.eu.